Company / Current Assets per Share
Supernus Pharmaceuticals, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$11.56
FY2025
5-year range
$8.88 / $13.79
FY2021-FY2025
Trend
-7.8%
vs FY2024
Sector context
#63 of 210
Health Care
What the data says
At $11.56, Supernus Pharmaceuticals, Inc.'s current assets per share ranks #63 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $3.09 in FY2016 to $13.79 in FY2022.
Based on SEC 10-K filings.
11.56 in FY2025 with a 5-year CAGR of -0.8%.
Improved from $8.88 to $11.56 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- -0.8%
- 10-Year CAGR
- -
Sector benchmark
#63 of 210 in Health CareTop 30% of 210This company $11.56 Sector average $170.65
▼
-93.2% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 7.8% year-over-year.
- Ranks #63 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.56 | -7.8% |
| FY2024 | $12.54 | +41.1% |
| FY2023 | $8.88 | -35.6% |
| FY2022 | $13.79 | +21.1% |
| FY2021 | $11.38 | -5.2% |
| FY2020 | $12.00 | +32.8% |
| FY2019 | $9.03 | -6.1% |
| FY2018 | $9.62 | +110.4% |
| FY2017 | $4.57 | +48.0% |
| FY2016 | $3.09 | +25.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026